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The prevalence of diabetes mellitus (DM) has dramatically increased in the past decade.
Furthermore, increasing evidence from research shows that oxidative stress (OS) plays a
crucial role in the pathogenesis of diabetes and in its complications. A search for ways to
reduce oxidative damage has become the focus of interest for the majority of scientists. In
this study, we determined the radical scavenging activity of single green tea constituents
by using an on-line high performance liquid chromatography (HPLC)e2,2-diphenyl-1-
picrylhydrazyl (DPPH) method and evaluated the antioxidant effects on type 2 diabetic
patients by performing a double-blind, placebo-controlled study. Epigallocatechin gallate
was identified as the most potent antioxidant, contributing approximately 50% of the total
antioxidant capacity of green tea extract. We also found a statistically significant decre-
ment of lipid peroxidation markers in patients treated with green tea extract after 9
months or after 18 months of follow-up. Overall, these findings are attractive for diabetic
patients, helping them to keep a high level of performance and well-being, which ulti-
mately may delay the time of disability and reduce mortality.
Copyright ª 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.Open access under CC BY-NC-ND license. 1. Introduction
Diabetes mellitus (DM) is undoubtedly one of the most chal-
lenging health problems in the 21st century. The worldChemistry, Faculty of Ph
uania.
(A. Spadiene).
ministration, Taiwan. Publprevalence of DM in 2012 was 8.3%, with an estimated number
of 371million carriers, and by 2030, this numbermay reach 552
million carriers. Half of individuals with diabetes are unaware
they have the disease [1]. Type 2DM is themost prevalent form
of this disease, comprising 90% of people with diabetes aroundarmacy, Medical Academy, Lithuanian University of Health Sci-
ished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license. 
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physical inactivity. The relative risk of death due to vascular
complications is at least double that in patients with DM than
in their peers without DM [2]. People with diabetes are at high
risk of major health problems earlier in life than those without
diabetes. Such a lifelong chronic disease sooner or later
adversely affects the emotional status and quality of life [3,4].
There is no doubt that oxidative stress (OS), in addition to the
abnormally high glucose concentration, plays a crucial role in
the pathogenesis of DM and its complications. There aremany
studies demonstrating an inseparable link betweenOS andDM
[5e9]. The mechanisms by which hyperglycemia can generate
reactive oxygen and nitrogen species (RONS) were thoroughly
explored by Jay et al [7] and later by Bandeira et al [5]. Increase
in mitochondrial RONS generation contributes to the estab-
lishment andmaintenance of OS, leading to insulin resistance
and alterations of the vasculature, kidneys, neurons, retina,
and pancreatic beta cells [6]. This increased RONS generation
causes the activation of the main pathways, described by
Giacco and Brownlee [9], which is involved in the pathogenesis
of DM complications. Patients with diabetes not only have
increased levels of RONS (circulating markers of free radical-
induced damage), but also reduced antioxidant defenses.
These may be due to a decrease in endogenous antioxidants,
as well as a depletion of dietary antioxidants and the other
essential components, iron overload and/or increased pro-
duction of RONS, the presence of toxins which produce such
species, or the excessive activation of natural producing sys-
tems of RONS [5,7]. Therefore, all of these parts are very
important for scientists searching for ways to slow down the
development of diabetic complications.
In response to the increasingly growing popularity and a
greater demand for medicinal plants, we decided to evaluate
the antioxidant properties of one of the most ancient and
popular, a plant green tea (Camellia sinensis L.) extract (Extract
Camellia sinensis (ECs)) for therapeutic use. Green tea is very
rich in polyphenolic constituents (most of which are flavo-
noids) which have high antiinflammatory, antioxidant, and
antimutagenic properties in various biological systems [10].
Polyphenolic compounds are well known to be responsible for
the antioxidant properties in many plants [11,12]. A major
class of green tea flavonoids is the catechins (the main one
being epigallocatechin-3-gallate), which play a key role as
antioxidants in prevention and treatment of many diseases
[10,13,14]. Green tea also contains flavonols (e.g., quercetin,
kaempferol, myricetin), phenolic acids (e.g., gallic and
chlorogenic acids), proanthocyanidins (prodelphinidin),
xanthic bases (caffeine, theophylline), polysaccharides,
essential amino acids (e.g., glycine, serine, valine, leucine,
threonine, and characteristic amino acid theanine), also vi-
tamins (B, C, E), and minerals and trace elements (calcium,
magnesium, manganese, copper, zinc, selenium, potassium)
[13,15]. Although the mechanism is not completely clear,
there is no doubt that ECs have beneficial effect on OS. Green
tea polyphenols can be direct antioxidants by scavenging
reactive oxygen species or chelating transition metals [10,16].
Alternatively, they may act indirectly by upregulating phase II
antioxidant enzymes [17].
The aim of this study was to identify the most active as
antioxidant ECs components and to evaluate the radicalscavenging activity of separate ECs active constituents using
an on-line high performance liquid chromatography (HPLC)e
2,2-diphenyl-1-picrylhydrazyl radicals (DDPH) method. The
antioxidant effects of ECs on type 2 diabetic patients were also
evaluated, by measuring the total antioxidant status (TAS),
activity of antioxidant enzymes [superoxide dismutase (SOD),
catalase (CAT) and glutathione peroxidase (GPx)] and the
amount of biomarkers for OS (lipid hydroperoxides (LOOH),
malondialdehyde (MDA), and 4-hydroxy-2-nonenal (HNE)].
Until now, there were no such clinical studies to evaluate
natural antioxidants, such as green tea extract, and effects on
the development of DM complications by reducing OS in
Europe. Moreover, the postcolumn HPLCeDPPH method for
determination and evaluation of the antioxidant activity of
the separated active constituents of ECs was used for the first
time.2. Materials and methods
2.1. HPLC method and chemicals
Chemicals of analytical purity were used. Trolox [(R)-6-
methoxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] was
received from Acros Organics (New York, USA), ethanol
(rectified spirit 96.3%) was received from Stumbras (Kaunas,
Lithuania), and sodium citrate and citric acid were received
from Fluka Chemie (Buchs, Switzerland). Methanol and
acetonitrile of HPLC gradient grade, as well as the commercial
standards of catechins, 2,2-diphenyl-1-picrylhydrazyl (DPPH)
radicals, ethyl acetate, glacial acetic acid and the rest of the
chemicals were received from Sigma-Aldrich Chemie (Stein-
heim, Germany). Ultrapure water from the Milli-Q system
(Millipore, Bedford, MA, USA) with conductivity of 18.2 MQ
was used in all experiments.
Chromatographic separation was performed by the
method of Saito et al [18] and was slightly modified as follows:
compounds were separated on an ACE C-18 column
(250  4.6 mm, 2.65 mm) with a precolumn (Advanced Chro-
matography Technologies, Aberdeen, Scotland) at 25C;
water/acetonitrile/methanol/ethyl acetate/glacial acetic acid
(89:6:1:3:1 v/v/v/v/v) was used as eluent A and acetonitrile as
eluent B. The mobile phase was delivered at 1.0 mL/minute in
a linear gradient mode: 0e10 minutes, 100% A and 0% B; 30
minutes, 85% A and 15% B; 40e45 minutes, 20% A and 80% B;
46 minutes, 100% A and 0% B.
The postcolumn HPLC-DPPH method described by Raudo-
nis et al [19] was used to evaluate the contribution of indi-
vidual constituents to antioxidant activity in ECs. A reference
antioxidant Trolox (chemical analog of vitamin E for polar-
solvent-soluble systems) was used for standardization of
antioxidant activity.
The DPPH radical scavenging activities of ECs active con-
stituents were calculated from the standard curve of Trolox at
concentrations of 0.02 mg/mL, 0.04 mg/mL, 0.06 mg/mL,
0.08 mg/mL, 0.1 mg/mL, and 0.12 mg/mL. The Trolox equiva-
lent antioxidant capacity (TEAC) was calculated for individual
constituents of ECs and expressed as micromoles of Trolox
equivalent (TE) per 100 g of dry extract (mmol TE/100 g).
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The randomized, double-blind, placebo-controlled study was
conducted in Endocrinology Clinic, Hospital of Lithuanian
University of Health Sciences Kaunas Clinics, Lithuania. The
experimental protocol used in this study was approved by the
Lithuanian Bioethics Committee, State Data Protection
Inspectorate (Number BE-2-5, 15 April 2009). Written,
informed, and voluntary consent was obtained from all par-
ticipants. All participants were outpatients of the Endocri-
nology Clinic, Hospital of Lithuanian University of Health
Sciences Kaunas Clinics, Kaunas, Lithuania. Individuals
diagnosed with type 2 DM (treated with insulin, metformin or
a combination of both) aged from 35 years to 80 years and
followed up for diabetic retinopathy, nephropathy, or neu-
ropathy, were enrolled into the study. They were not deprived
of taking their regular prescribed medications, but were
advised to abstain from other dietary supplements rich in
antioxidants.
The status of type 2 diabetes and its complications, OS
parameters, and biochemical measurements were evaluated
at the baseline. The baseline measurements were repeated
after 9 months and 18 months of receiving preparations.
During the first 9 months, patients received capsules twice a
day, and during the second 9 months, they received capsules
three times a day.
2.3. Study preparations
All patients were randomly allocated to receive either green
tea extract or placebo capsules. Placebo capsules were made
from microcrystalline cellulose, a material indifferent to dis-
ease (joint-stock company, Sanitas, Kaunas, Lithuania). An
ECs capsule contains 200mg standardized extract of C. sinensis
L. leaves, adjusted to 70% polyphenols (Sanitas). Dry Green tea
extract for the production of capsuleswas received fromTaiyo
GmbH (Filderstadt, Germany). The origin of raw material was
China.
2.4. Biochemical measurements
All measurements of plasma OS parameters were performed
in the Laboratory of Biochemistry, Riga Stradins University,
Riga, Latvia. Determination of antioxidative enzymes SOD [20],
CAT [21], selenium dependent GPx [22], and TAS [23] were
performed on an automatic chemical analyzer “Dayton RX”
based on spectrophotometer methods according to the in-
structions provided by Randox Laboratories and using its own
kits (Randox Laboratories Limited, Crumlin, UK). The degree of
lipid peroxidation was evaluated by quantitative determina-
tion of LOOH [24] using a commercial diagnostic kit (Northwest
LSS Inc., Washington, USA) and concentration of MDA þ HNE
[25] using an LPO Microplate Based Assay Kit, Cat. Number
FR22 (Oxford Biomedical Research, Michigan, USA) on a
microplate absorbance reader (Tecan, Grodig, Austria). The
manuals of standard methods with reagents from Sigma-
Aldrich (Missouri, USA) were used to determine the concen-
tration of selenium [26] and vitamin E [27]. The control serums
Seronorm TE Serum level I (Cat. Number 201 405) and vitamin
A/E level II (Cat. Number 007.002.018) used for quality controlof selenium and vitamin E were received from Sero AS (Bill-
ingstad, Norway) and Eurotrol (Ede, Netherlands), respectively.
2.5. Statistical analysis
Data were analyzed using SSPS version 20.0 (SPSS Inc., Chi-
cago, IL, USA) for Windows and Microsoft Excel 2010 (Micro-
soft, Redmond, WA, USA). Data are expressed as
mean  standard deviation (S.D.). Nonparametric tests were
used because of the small number of variables. The compar-
isons between the two groups (placebo and ECs) weremade by
theMann-WhitneyU test at each time point. The comparisons
between three different measurements were made using
Friedman and Wilcoxon tests. The results were considered
statistically significant at p < 0.05.3. Results and discussion
3.1. Antioxidant activity of individual constituents of
ECs
The antioxidant activity of ECs mainly depends on catechins
and their ability to scavenge free radicals [10,16]. In this
research, we evaluated the antioxidant activity of the main
green tea catechins, which are in the highest amount in the
extract, (catechin, epicatechin, epigallocatechin, epicatechin-
3-gallate, and epigallocatechin-3-gallate) and their contribu-
tion to the total antioxidant activity of ECs. All experiments
were performed in triplicate. An example of the chromato-
grams of ECs obtained by performing evaluation of active
compounds of ECs by the on-line HPLC-DDPH method is pre-
sented in Fig. 1. The DDPH scavenging activity of all constit-
uents was expressed as TEs. All catechins, except catechin
(which is in smaller quantity in extract), possessed a good
DPPH radical scavenging activity. Epigallocatechin-3-gallate
presented the highest DPPH scavenging activity
(23.41  5.73 mmol TE/100 g), followed by epicatechin-3-gallate
(16.36 3.84 mmol TE/100 g), epigallocatechin (4.06 0.24 mmol
TE/100 g), epicatechin (1.57  020 mmol TE/100 g), and finally
catechin (0.15  0.02 mmol TE/100 g). Approved domination of
the free radical scavenging activity of the catechin fraction
against the other phenolic green tea compounds in the med-
ical product by such a method was established for the first
time. Our results are consistent with the findings by Nanjo
et al [28] in the past century, who reported that the ortho-
trihydroxyl group in the B ring (in epigallocatechin and epi-
gallocatechin-3-gallate) and the galloyl moiety at the 3 posi-
tion of flavan-3-ol skeleton (in epicatechin-3-gallate and
epigallocatechin-3-gallate) are the most important in scav-
enging ability on the DPPH radical. All subsequent research
confirmed that epigallocatechin-3-gallate (the most abundant
of the catechins) exhibit the highest radical scavenging ac-
tivity and antioxidant activity of ECs [16]. Meanwhile, the data
of epigallocatechin and epicatechin-3-gallate antioxidant ac-
tivity are contradictory. Our research data, according to the
antioxidant activity, shows that catechins can be arranged as
follows: epigallocatechin-3-gallate > epicatechin-3-gallate
> epigallocatechin > epicatechin > catechin. The same suc-
cession was also described by Higdon and Frei [29].
Fig. 1 e (A) High performance liquid chromatography (HPLC); and (B) UVe2,2-diphenyl-1-picrylhydrazyl (DPPH)
chromatograms of the Extract Camellia sinensis. Peaks: 1. epigallocatechin, 2. catechin, 3. epicatechin, 4. epigallocatechin-3-
gallate, and 5. epicatechin-3-gallate.
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ECs and its main constituents, catechins, undoubtedly have
antioxidant properties that were also confirmed by our study.
We wanted to evaluate whether natural antioxidants present
in Camellia sinensis L. leaves extract are capable of protecting
or reducing oxidative damage in diabetic patients with com-
plications. Because the OS plays a crucial role in the patho-
genesis of DM and its complications [5e9] and there are a large
number of previous studies demonstrating beneficial effects
of ECs on OS [10,13,17], we expected to receive significant ev-
idence of a reduction in the amount of lipid peroxidation
markers and/or an increase in activity of antioxidant
enzymes.
Currently, the results are from 45 patients who finished
the study (20 patients in the ECs group and 25 in the placebo
group). The age and duration of DM were similar in both
groups. The mean age was 62.18  10.37 years and the mean
duration of DM was 11.76  11.4 years. All patients were
over 60 years with a long duration of diabetes and more
progressive diabetic complications. The mean level of gly-
cated hemoglobin was 7.81  1.64% and there were no sig-
nificant changes of glycated hemoglobin during the study in
both groups. In the diabetic state, hyperglycemia per se gen-
erates RONS production [5,30]. Additionally, factors such as
obesity, smoking, sedentary lifestyles, hypertension, a long
duration of DM, and age may contribute to the establishment
and maintenance of OS, leading to the aggravation of type2 diabetes. In our study, most of the patients were obese. The
mean body mass index was 35.23  4.98 and 34.98  6.44,
respectively, in ECs and placebo groups. Waist circumference
was greater in the ECs and placebo groups compared to hip
circumference, in 47.4% and 39.1% of patients, respectively.
An increase in the waistehip ratio also incident to DM
and demonstrates the greater risk of lifestyle related dis-
eases. Other factors (such as hypertension and smoking) that
can influence RONS production were not of great importance.
Only 8.9% of patients (3 patients in the ECs and 1 in the
placebo group) reported that they smoked, whereas the rest
of the respondents did not smoke or had quit smoking when
DM was diagnosed. Hypertension, which occurred in 65%
of patients and 80% of patients in the ECs and placebo
groups, respectively, was well controlled by antihypertensive
drugs.
All investigated OS parameters of both groups and at
different time points of the study are shown in Table 1. The
amounts of MDA, HNE, and LOOH were increased in the
beginning of the study. In response to the increased activity of
lipid peroxidation, we did not observe an effective compen-
satory increase in indicators of the antioxidant defense sys-
tem. This confirms the hypothesis that RONS generation and
lipid peroxidation processes are accelerated in diabetic pa-
tients. Moreover, although the amount of antioxidant en-
zymeswerewithin established reference ranges, a decrease in
the content of selenium, which is essential for the activity of
GPx [31], was observed at the beginning of study.
Table 1 e Comparison of the investigated parameters between groups at baseline, after 9 months, and after 18 months.
Group At baseline (I) After 9 mo (II) After 18 mo (III) p
SOD (U/g Hb) ECs 1360.75  140.9 1450.05  170.6 1410.75  131,6 IeII p ¼ 0.022
Placebo 1406.20  139.5 1487.24  128.8 1464.04  143.0 IeII p ¼ 0.010,
IeIII p ¼ 0.042
p NS NS NS
CAT (k/g Hb) ECs 229.05  74.1 219.11  61.5 237.82  65.3
Placebo 211.75  60.1 242.48  68.5 206.04  79.4 IIeIII p ¼ 0.017
p NS NS NS
GPx (U/L) ECs 6971.05  2006.5 7586.80  2865.9 6561.19  1560.0
Placebo 6398.28  1964.3 7311.70  2024.7 6787.78  1670.7 IeII p ¼ 0.045
p NS NS NS
Vitamin E (mg/mL) ECs 13.41  4.3 13.58  4.7 13.96  5.2
Placebo 15.81  4.4 13.18  3.9 12.03  3.3 IeII p ¼ 0.004,
IIeIII p ¼ 0.037,
IeIII p < 0.001
p NS NS NS
TAS (mmol/L) ECs 1.64  0.16 1.67  0.18 1.66  0.12
Placebo 1.54  0.17 1.67  0.19 1.60  0.17
p NS NS NS
Se (mg/L) ECs 78.50  16.76
Placebo 77.52  15.79
p NS
MDA (mM) ECs 1.81  0.66 1.51  0.40 1.62  0.80 IeII p ¼ 0.022,
IeIII p ¼ 0.047
Placebo 1.84  1.28 1.68  0.51 1.89  1.20
p NS NS NS
HNE (mM) ECs 4.36  3.46 4.58  3.22 4.54  1.95
Placebo 6.51  5.00 5.69  2.64 5.01  3.14
p NS NS NS
MDA  HNE
(mM)
ECs 5.99  3.73 6.21  3.10 6.16  2.29
Placebo 7.77  5.24 7.37  2.65 6.92  3.62
p NS NS NS
LOOH (mM) ECs 7.80  3.7 5.88  2.9 7.30  5.6
Placebo 8.58  5.4 6.95  3.4 7.26  4.2
p NS NS NS
CAT ¼ catalase; ECs ¼ Extract Camellia sinensis; GPx ¼ glutathione peroxidase; HNE ¼ 4-hydroxy-2-nonenal; LOOH ¼ lipid hydroperoxides;
MDA ¼ malondialdehyde; Se ¼ Selenium; SOD ¼ superoxide dismutase ; TAS ¼ total antioxidant status.
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patients with type 2 diabetes as compared with the placebo
group either after 9 months or after 18 months of follow-up.
However, there were some noticeable changes within the
groups. The activity of SOD significantly increased in ECs
group after 9 months, whereas the changes of other antioxi-
dant enzymeswere insignificant and numerically small. In the
placebo group, a significant increment of SOD after 9 months
and 18 months was observed, and a significant increment of
GPx was observed after the first 9 months. Meanwhile, the
activity of CAT significantly decreased after the second 9
months in the placebo group. These findings do not match
with those previously described by Forester and Lambert [17].
These differences may be due to the total body damage by a
long duration of diabetes and rapidly progressive diabetic
complications, as well as longer lasting exhausting effects of
OS. Also, we found a statistically significant decrement of
content of vitamin E in the placebo group after both 9 months
and 18 months. A trend of a slight increment of vitamin E,
albeit insignificant and numerically small, was observed in
the ECs group during the study. In agreement with other
studies [10,32], these data showed a beneficial effect of ECs onoxidative damage by reducing the amount of lipid peroxida-
tionmarkers. A decrement of LOOH andMDAwas observed in
the ECs group as compared with the placebo group; the
changes in lipid peroxidation markers were not statistically
significant. Because ECs have strong antioxidant properties,
we expected to see more differences between the ECs group
and the placebo group. Supposedly, it was influenced by the
older age of patients, already existing significant diabetic
complications, and the duration of the study, but further
exploration needs to be done to evaluate the effects of green
tea extracts, maybe in patients with early diabetic complica-
tions. However, our findings confirm the benefits of green tea
extract when lipid peroxidation is increased and there is an
insufficient natural antioxidant defense system.
ECs capsules used in this study were manufactured by
Sanitas. Considering the manufacturer’s recommendations,
two to three capsules of this dietary supplement should be
taken daily, which is equivalent to 280e420 mg polyphenols.
Most of the previous studies indicate antioxidant effects of
green tea extract after consumption of 400e500 mg green tea
polyphenols for 2 months, 3 months, or 6 months [17,33e35].
Although the manufacturer’s recommended dose is smaller
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uatewhether the lower dose used over a long time could cause
antioxidant effects in diabetic patients. A 9 month study
duration was chosen in order to evaluate the long term effects
of ECs on the development of diabetic complications. Ac-
cording to the data, the concentration of ECs was not of great
importance. However, there were some changes between the
first 9 months and the second 9 months (when patients
received capsules twice a day and 3 times a day, respectively),
but these changes were insignificant both in the ECs group
and the placebo group.4. Conclusion
Epigallocatechin gallate was identified as the most potent
antioxidant, with a TEAC value of 23.41  5.73 mmol TE/100 g,
contributing to approximately 50% of the total antioxidant
capacity of green tea extract. The antioxidant properties of
ECs catechins increase in the order: catechin < epicatechin <
epigallocatechin< epicatechin-3-gallate< epigallocatechin-3-
gallate.
The findings of this study confirm the beneficial influence
of green tea extract on reducing the amount of MDA and
LOOH, although significant changes between the ECs and
placebo groups were not observed. The present findings are
not beneficial in diabetic patients with more acute diabetic
complications and further study in different circumstances
needs to be performed. Nevertheless, the findings are attrac-
tive for diabetic patients, especially with a shorter duration of
DM, helping them to keep a high level of performance and
well-being, which ultimately may delay the time of disability
and reduce mortality.Conflicts of interest
All authors declare no conflicts of interest.
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